Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: Implications for chronic inflammation

Current Issues in Intestinal Microbiology

Volumn 8, Issue 2, 2007, Pages 25-43

  Clavell, Thomas ^a   Haller, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; JANUS KINASE 1; MESALAZINE; MITOGEN ACTIVATED PROTEIN KINASE 14; PATTERN RECOGNITION RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGER PROTEIN;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; COLITIS; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ENTEROBACTERIACEAE; GASTROINTESTINAL TRACT; GENETIC SUSCEPTIBILITY; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LAMINA PROPRIA; MESENTERY LYMPH NODE; MICROBIOLOGY; MOLECULAR INTERACTION; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

ANIMALS; BACTERIA; CHRONIC DISEASE; EPITHELIUM; GERM-FREE LIFE; GUINEA PIGS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RATS; RATS, INBRED F344;

ENTEROBACTERIACEAE;

EID: 34249052239     PISSN: 1466531X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (183)

1. Alexander, W.S., and Hilton, D.J. (2004). The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22, 503-529.
2. Allez, M., and Mayer, L. (2004). Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. 10, 666-676.
3. Andresen, L., Jorgensen, V.L., Pemer, A., Hansen, A., Eugen-Olsen, J., and Rask-Madsen, J. (2005). Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54, 503-509.
4. Araki, Y., Andoh, A., Takizawa, J., Takizawa, W., and Fujiyama, Y. (2004). Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int. J. Mol. Med. 13, 577-580.
5. Auwerx, J. (2002). Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain? Am. J. Physiol. Gastrointest. Liver Physiol. 282, G581-585.
6. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., and Gordon, J.I. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 101, 15718-15723.
7. Balish, E., and Warner, T. (2002). Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160, 2253-2257.
8. Bashir, M.E., Louie, S., Shi, H.N., and Nagler-Anderson, C. (2004). Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 172, 6978-6987.
9. Beagley, K.W., and Husband, A.J. (1998). Intraepithelial lymphocytes: origins, distribution, and function. Crit. Rev. Immunol. 18, 237-254.
10. Berg, D.J., Davidson, N., Kuhn, R., Muller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M.W., and Rennick, D. (1996). Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98, 1010-1020.
11. Beutler, B. (2000). Tlr4: central component of the sole mammalian LPS sensor. Curr Opin. Immunol. 12, 20-26.
12. Beyaert, R., Heyninck, K., and Van Huffel, S. (2000). A20 and A20-binding proteins as cellular inhibitors of nuclear factor- kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60, 1143-1151.
13. Bibiloni, R., Fedorak, R.N., Tannock, G.W., Madsen, K.L., Gionchetti, P., Campieri, M., De Simone, C., and Sartor, R.B. (2005a). VSL #3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100, 1539-1546.
14. Bibiloni, R., Simon, M.A., Albright, C., Sartor, B., and Tannock, G.W. (2005b). Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Lett. Appl. Microbiol. 41, 45-51.
15. Blanquart, C., Barbier, O., Fruchart, J.C., Staels, B., and Glineur, C. (2003). Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85, 267-273.
16. Boirivant, M., Pallone, F., Di Giacinto, C., Fina, D., Monteleone, I., Marinaro, M., Caruso, R., Colantoni, A., Palmieri, G., Sanchez, M., et al. (2006). Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Gastroenterology 131, 1786-1798.
17. Boone, D.L., Lee, E., Chai, S., Gibson, P, Tam, J., Libby, S., Chang, J., Chan, F., Chien, M., and Ma, A. (2003). A20 is required for the negative regulation of LPS-induced NF-kappab in macrophages. Gastroenterology 124, A45.
18. Braat, H., Rottiers, P., Hommes, D.W., Huyghebaert, N., Remaut, E., Remon, J.P., van Deventer, S.J., Neirynck, S., Peppelenbosch, M.P., and Steidler, L. (2006). A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4, 754-759.
19. Brandtzaeg, P., Farstad, I.N., and Haraldsen, G. (1999). Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol. Today 20, 267-277.
20. Breitbart, M., Hewson, I., Felts, B., Mahaffy, J.M., Nulton, J., Salamon, P., and Rohwer, F. (2003). Metagenomic analyses of an uncultured viral community from human feces. J. Bacteriol. 185, 6220-6223.
21. Burns, K., Martinon, F., Esslinger, C., Pahl, H., Schneider, P., Bodmer, J.-L., Di Marco, F., Frech, L., and Tschopp, J. (1998). MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273, 12203-12209.
22. Camerini, V., Sydora, B.C., Aranda, R., Nguyen, C., MacLean, C., McBride, W.H., and Kronenberg, M. (1998). Generation of intestinal mucosal lymphocytes in SCID mice reconstituted with mature, thymus-derived T cells. J. Immunol. 160, 2608-2618.
23. Cao, Z., Henzel, W.J., and Gao, X. (1996). IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131.
24. Cario, E., Brown, D., Mckee, M., Lynch-Devaney, K., Gerken, G., and Podolsky, D.K. (2002). Commensal-associated molecular patterns induce selective Toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160, 165-173.
25. Cario, E., Gerken, C., and Podolsky, D.K. (2004). Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224-238.
26. Cario, E., and Podolsky, D.K. (2000). Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017.
27. Cash, H.L., Whitham, C.V., Behrendt, C.L., and Hooper, L.V. (2006). Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130.
28. Cebra, J.J. (1999). Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69, 1046S-1051S.
29. Chen, L.W., Egan, L., Li, Z.W., Greten, F.R., Kagnoff, M.F., and Karin, M. (2003). The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9, 575-581.
30. Chen, X., Kokkotou, E.G., Mustafa, N., Bhaskar, K.R., Sougioultzis, S., O'Brien, M., Pothoulakis, C., and Kelly, C.P. (2006). Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J. Biol. Chem. 281, 24449-24454.
31. Christ, A.D., Colgan, S.P., Balk, S.P., and Blumberg, R.S. (1997). Human intestinal epithelial cell lines produce factor(s) that inhibit CD3-mediated T-lymphocyte proliferation. Immunol. Left. 58, 159-165.
32. Chuang, T.H., and Ulevitch, R.J. (2004). Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 5, 495-502 Epub 2004 Apr 2025.
33. Conte, M.P., Schippa, S., Zamboni, I., Penta, M., Chiarini, F., Seganti, L., Osborn, J., Falconieri, P., Borrelli, O., and Cucchiara, S. (2006). Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55, 1760-1767.
34. Croston, G.E., Cao, Z., and Goeddel, D.V. (1995). NF-kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor- associated protein kinase activity. J. Biol. Chem. 270, 16514-16517.
35. Dalmasso, C., Cottrez, F., Imbert, V., Lagadec, R, Peyron, J.F., Rampal, P., Czerucka, D., and Groux, H. (2006). Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 131, 1812-1825.
36. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.L., Barnich, N., Bringer, M.A., Swidsinski, A., Beaugerie, L., and Colombel, J.F. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421.
37. Daun, J.M., and Fenton, M.J. (2000). Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. J. Interferon Cytokine Res. 20, 843-855.
38. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. (1999). Positive and negative regulation of IkB kinase activity through IKKb subunit phosphorylation. Science 284, 309-313.
39. Delhase, M., Li, N., and Karin, M. (2000). Kinase regulation in inflammatory response. Nature 406, 367-368.
40. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., and Boirivant, M. (2005). Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 174, 3237-3246.
41. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., and Karin, M. (1996). Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295-1304.
42. Dubuquoy, L., Jansson, E.A., Deeb, S., Rakotobe, S., Karoui, M., Colombel, J.F., Auwerx, J., Pettersson, S., and Desreumaux, P. (2003). Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124, 1265-1276.
43. Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K., and Meyer zum Buschenfelde, K.H. (1995). Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102, 448-455.
44. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., and Tsichlis, P.N. (2000). TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083.
45. Fagarasan, S., and Honjo, T. (2004). Regulation of IgA synthesis at mucosal surfaces. Curr. Opin. Immunol. 16, 277-283.
46. Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K., Lefebvre, A.M., Saladin, R., Najib, J., Laville, M., Fruchart, J.C., Deeb, S., et al. (1997). The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272, 18779-18789.
47. Falk, P.G., Hooper, L.V., Midtvedt, T., and Gordon, J.I. (1998). Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170.
48. Fitzgerald, K.A., Palsson-McDermott, E.M., Bowie, A.G., Jefferies, C.A., Mansell, A.S., Brady, G., Brint,E., Dunne, A., Gray, P., Harte, M.T., et al. (2001). Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83.
49. Freter, R., and Abrams, G.D. (1972). Function of various intestinal bacteria in converting germfree mice to the normal state. Infect. Immun. 6, 119-126.
50. Fuss, I.J., Boirivant, M., Lacy, B., and Strober, W. (2002). The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J. Immunol. 168, 900-908.
51. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., and Campieri, M. (2003). Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124, 1202-1209.
52. Gordon, J.I., Hooper, L.V., McNevin, M.S., Wong, M., and Bry, L. (1997). Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. Am. J. Physiol. 273, G565-570.
53. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D.C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R.R., et al. (2006). Escherichia coli strain Nissle 1917 ameliorates experimental colitis via Toll-like receptor 2- and Toll-like receptor 4-dependent pathways. Infect. Immun. 74, 4075-4082.
54. Guslandi, M., Giollo, P., and Testoni, P.A. (2003). A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 15, 697-698.
55. Hahm, K.B., Im, Y.H., Parks, T.W., Park, S.H., Markowitz, S., Jung, H.Y., Green, J., and Kim, S.J. (2001). Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49, 190-198.
56. Haller, D. (2006). Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol Motil. 18, 184-199.
57. Haller, D., Holt, L., Kim, S.C., Schwabe, R.F., Sartor, R.B., and Jobin, C. (2003). Transforming growth factor-{beta}1 inhibits non-pathogenic gramnegative bacteria-induced NF-{kappa}B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J. Biol. Chem. 278, 23851-23860.
58. Haller, D., and Jobin, C. (2004). Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J. Pediatr. Gastroenterol. Nutr. 38, 123-136.
59. Haller, D., Russo, M.P., Sartor, R.B., and Jobin, C. (2002a). IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J. Biol. Chem. 277, 38168-38178.
60. Haller, D., Serrant, P., Peruisseau, G., Bode, C., Hammes, W.P., Schiffrin, E., and Blum, S. (2002b). IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteria. Microbiol. Immunol. 46, 195-205.
61. Hara, M., Kingsley, C.I., Niimi, M., Read, S., Turvey, S.E., Bushell, A.R., Morris, P.J., Powrie, F., and Wood, K.J. (2001). IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796.
62. Hart, A.L., Al-Hassi, H.O., Rigby, R.J., Bell, S.J., Emmanuel, A.V., Knight, S.C., Kamm, M.A., and Stagg, A.J. (2005). Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129, 50-65.
63. Hausmann, M., Kiessling, S., Mestermann, S., Webb, G., Spottl, T., Andus, T., Scholmerich, J., Herfarth, H., Ray, K., Falk, W., and Rogler, G. (2002). Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122, 1987-2000.
64. Hayashi, F., Smith, K.D., Ozinsky, A., Hawn, T.R., Yi, E.C., Goodlett, D.R., Eng, J.K., Akira, S., Underhill, D.M., and Aderem, A. (2001). The innate immune response to bacterial flagellin is mediated by Toll- like receptor 5. Nature 410, 1099-1103.
65. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
66. Hendershot, L.M., Wei, J.Y., Gaut, J.R., Lawson, B., Freiden, P.J., and Murti, K.G. (1995). In vivo expression of mammalian BiP ATPase mutants causes disruption of the endoplasmic reticulum. Mol. Biol. Cell 6, 283-296.
67. Hermiston, M.L., and Gordon, J.I. (1995). Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270, 1203-1207.
68. Holtmann, M.H., Schutz, M., Galle, P.R., and Neurath, M.F. (2002). Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases. Z. Gastroenterol. 40, 587-600.
69. Hooper, L.V., Wong, M.H., Thelin, A., Hansson, L., Falk, P.G., and Gordon, J.I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884.
70. Hooper, L.V., Xu, J., Falk, P.G., Midtvedt, T., and Gordon, J.I. (1999). A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA. 96, 9833-9838.
71. Hornef, M.W., Frisan, T., Vandewalle, A., Normark, S., and Richter-Dahlfors, A. (2002). Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195, 559-570.
72. Horng, T., Barton, G.M., and Medzhitov, R. (2001). TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841.
73. Hu, P., Han, Z., Couvillon, A.D., Kaufman, R.J., and Exton, J.H. (2006). Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 26, 3071-3084.
74. Iwakura, Y., and Ishigame, H. (2006). The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218-1222.
75. Jiang, C., Ting, A.T., and Seed, B. (1998). PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
76. Jones, S.C., Banks, R.E., Haidar, A., Gearing, A.J., Hemingway, I.K., Ibbotson, S.H., Dixon, M.F., and Axon, A.T. (1995). Adhesion molecules in inflammatory bowel disease. Gut 36, 724-730.
77. Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., and Raz, E. (2005). Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115, 695-702.
78. Katayama, K., Wada, K., Nakajima, A., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Kadowaki, T., Nagai, R., Kamisaki, Y., Blumberg, R.S., and Mayumi, T. (2003). A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 124, 1315-1324.
79. Kelly, D., Campbell, J.I., King, T.P, Grant, G., Jansson, E.A., Coutts, A.G., Pettersson, S., and Conway, S. (2004). Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and ReIA. Nat. Immunol. 5, 104-112 Epub 2003 Dec 2021.
80. Khoo, U.Y., Proctor, I.E., and Macpherson, A.J. (1997). CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. J. Immunol. 158, 3626-3634.
81. Kim, S.C., Tonkonogy, S.L., Albright, C.A., Tsang, J., Balish, E.J., Braun, J., Huycke, M.M., and Sartor, R.B. (2005). Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128, 891-906.
82. Kitani, A., Fuss, I.J., Nakamura, K., Schwartz, O.M., Usui, T., and Strober, W. (2000). Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain down regulation. J. Exp. Med. 192, 41-52.
83. Kleessen, B., Kroesen, A.J., Buhr, H.J., and Blaut, M. (2002). Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37, 1034-1041.
84. Kobayashi, K., Hernandez, L.D., Galan, J.E., Janeway, C.A., Jr., Medzhitov, R., and Flavell, R.A. (2002). IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202.
85. Kraehenbuhl, J.P., and Neutra, M.R. (2000). Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16, 301-332.
86. Kraus, T.A., and Mayer, L. (2005). Oral tolerance and inflammatory bowel disease. Curr. Opin. Gastroenterol. 21, 692-696.
87. Kraus, T.A., Toy, L., Chan, L., Childs, J., and Mayer, L. (2004). Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 126, 1771-1778.
88. Kuhbacher, T., Ott, S.J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Gionchetti, P., Blaut, M., Campieri, M., Folsch, U.R., et al. (2006). Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55, 833-841.
89. Kulkami, A.B., Ward, J.M., Yaswen, L., Mackall, C.L., Bauer, S.R., Huh, C.G., Gress, R.E., and Karlsson, S. (1995). Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am. J. Pathol. 146, 264-275.
90. Lawrence, T., Gilroy, D.W., Colville-Nash, P.R., and Willoughby, D.A. (2001). Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7, 1291-1297.
91. Lee, T.S., and Chau, L.Y. (2002). Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240-246.
92. Lepage, P., Seksik, P., Sutren, M., de la Cochetiere, M.F., Jian, R., Marteau, P., and Dore, J. (2005). Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm. Bowel Dis. 11, 473-480.
93. Lopez-Boado, Y.S., Wilson, C.L., Hooper, L.V., Gordon, J.I., Hultgren, S.J., and Parks, W.C. (2000). Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J. Cell Biol. 148, 1305-1315.
94. Lotz, M., Gutle, D., Walther, S., Menard, S., Bogdan, C., and Hornef, M.W. (2006). Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203, 973-984.
95. MacDonald, T.T., and Carter, P.B. (1979). Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J. Immunol. 122, 2624-2629.
96. Mackie, R.I., Sghir, A., and Gaskins, H.R. (1999). Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69, 10355-10455.
97. Macpherson, A.J., Gatto, D., Sainsbury, E., Harriman, G.R., Hengartner, H., and Zinkernagel, R.M. (2000). A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288, 2222-2226.
98. Macpherson, A.J., and Harris, N.L. (2004). Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478-485.
99. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., and De Simone, C. (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580-591.
100. Madsen, K.L., Doyle, J.S., Jewell, L.D., Tavernini, M.M., and Fedorak, R.N. (1999). Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107-1114.
101. Mahler, M., Bristol, I.J., Leiter, E.H., Workman, A.E., Birkenmeier, E.H., Elson, C.O., and Sundberg, J.P. (1998). Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274, G544-551.
102. Malinin, N.L., Boldin, M.P., Kovalenko, A.V., and Wallach, D. (1997). MAP3K-related kinase involved in NF-kB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
103. Maloy, K.J., Salaun, L., Cahill, R., Dougan, G., Saunders, N.J., and Powrie, F. (2003). CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119.
104. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
105. Mao, Y, Nobaek, S., Kasravi, B., Adawi, D., Stenram, U., Molin, G., and Jeppsson, B. (1996). The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111, 334-344.
106. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and Kasper, D.L. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118.
107. Melmed, G., Thomas, L.S., Lee, N., Tesfay, S.Y., Lukasek, K., Michelsen, K.S., Zhou, Y., Hu, B., Arditi, M., and Abreu, M.T. (2003). Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170, 1406-1415.
108. Monteleone, G., Del Vecchio Blanco, G., Monteleone, I., Fina, D., Caruso, R., Gioia, V., Ballerini, S., Federici, G., Bernardini, S., Pallone, F., and MacDonald, T.T. (2005). Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129, 1420-1429.
109. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
110. Mowat, A.M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3, 331-341.
111. Muzio, M., Ni, J., Feng, R., and Dixit, V.M. (1997). IRAK (Pelle) family IRAK-2 and MyD88 as proximal mediator of IL-1 signaling. Science 278, 1612-1615.
112. Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L.J., Kadowaki, T., Blumberg, R.S., et al. (2001). Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120, 460-469.
113. Neish, A.S. (2002). The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect. 4, 309-317.
114. Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., Rao, A.S., and Madara, J.L. (2000). Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289, 1560-1563.
115. Neurath, M.F., Fuss, I., Kelsall, B.L., Presky, D.H., Waegell, W., and Strober, W. (1996a). Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J. Exp. Med. 183, 2605-2616.
116. Neurath, M.F., Pettersson, S., Meyer zum Buschenfelde, K.H., and Strober, W. (1996b). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2, 998-1004.
117. Neutra, M.R., Mantis, N.J., and Kraehenbuhl, J.P. (2001). Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2, 1004-1009.
118. Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas, J.M., Boes, M., Ploegh, H.L., Fox, J.G., et al. (2005). CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258.
119. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., and Matsumoto, K. (1999). The kinase TAK 1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signaling. Nature 398, 252-256.
120. Ogawa, H., Fukushima, K., Naito, H., Funayama, Y., Unno, M., Takahashi, K., Kitayama, T., Matsuno, S., Ohtani, H., Takasawa, S., et al. (2003). Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm. Bowel Dis. 9, 162-170.
121. Ohkawara, S., Furuya, H., Nagashima, K., Asanuma, N., and Hino, T. (2006). Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice. Clin. Vaccine Immunol. 13, 1231-1236.
122. Onderdonk, A.B., Franklin, M.L., and Cisneros, R.L. (1981). Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect. Immun. 32, 225-231.
123. Otte, J.M., Cario, E., and Podolsky, D.K. (2004). Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126, 1054-1070.
124. Pahl, H.L. (1999a). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
125. Pahl, H.L. (1999b). Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol. Rev. 79, 683-701.
126. Pahl, H.L., and Baeuerle, PA. (1995). A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. Embo J. 14, 2580-2588.
127. Panwala, C.M., Jones, J.C., and Viney, J.L. (1998). A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 161, 5733-5744.
128. Pena, J.A., Li, S.Y., Wilson, P.H., Thibodeau, S.A., Szary, A.J., and Versalovic, J. (2004). Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis. Appl. Environ. Microbiol. 70, 558-568.
129. Petrof, E.O., Kojima, K., Ropeleski, M.J., Musch, M.W., Tao, Y., De Simone, C., and Chang, E.B. (2004). Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127, 1474-1487.
130. Powrie, F., Correa-Oliveira, R., Mauze, S., and Coffman, R.L. (1994). Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179, 589-600.
131. Rachmilewitz, D., Karmeli, F., Takabayashi, K., Hayashi,T., Leider-Trejo, L., Lee, J., Leoni, L.M., and Raz, E. (2002). Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122, 1428-1441.
132. Rakoff-Nahoum, S., Hao, L., and Medzhitov, R. (2006). Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25, 319-329.
133. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
134. Rao, R.V., Peel, A., Logvinova, A., del Rio, G., Hermel, E., Yokota, T., Goldsmith, P.C., Ellerby, L.M., Ellerby, H.M., and Bredesen, D.E. (2002). Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Let 514, 122-128.
135. Rath, H.C., Wilson, K.H., and Sartor, R.B. (1999). Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Eschenchia coli. Infect. Immun. 67, 2969-2974.
136. Rawis, J.F., Mahowald, M.A., Ley, R.E., and Gordon, J.I. (2006). Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127, 423-433.
137. Rembacken, B.J., Snelling, A.M., Hawkey, P.M., Chalmers, D.M., and Axon, A.T. (1999). Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635-639.
138. Resta-Lenert, S., and Barrett, K.E. (2003). Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52, 988-997.
139. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79-82.
140. Rothkotter, H.J., and Pabst, R. (1989). Lymphocyte subsets in jejunal and ileal Peyer's patches of normal and gnotobiotic minipigs. Immunology 67, 103-108.
141. Ruiz, P.A., Hoffmann, M., Szcesny, S., Blaut, M., and Haller, D. (2005a). Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115, 441-450.
142. Ruiz, P.A., Kim, S.C., Balfour Sartor, R., and Haller, D. (2004). 15-deoxy-Delta{12, 14}-prostaglandin J2-mediated ERK signaling inhibits gram negative bacteria-induced ReIA phosphorylation and IL-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. J. Biol. Chem. 21, 21.
143. Ruiz, P.A., Shkoda, A., Kim, S.C., Sartor, R.B., and Haller, D. (2005b). IL-10 gene deficient mice lack TGF-beta/Smad signaling and fail to inhibit pro-inflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J. Immunol. 174.
144. Sanderson, J.D., Moss, M.T., Tizard, M.L., and Hermon-Taylor, J. (1992). Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33, 890-896.
145. Sansonetti, P.J. (2004). War and peace at mucosal surfaces. Nat. Rev. Immunol. 4, 953-964.
146. Sartor, R.B. (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390-407.
147. Saubermann, L.J., Nakajima, A., Wada, K., Zhao, S., Terauchi, Y., Kadowaki, T., Aburatani, H., Matsuhashi, N., Nagai, R., and Blumberg, R.S. (2002). Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm. Bowel Dis. 8, 330-339.
148. Savage, D.C., Dubos, R., and Schaedler, R.W. (1968). The gastrointestinal epithelium and its autochthonous bacterial flora. J. Exp. Med. 127, 67-76.
149. Schmid, R.M., and Adler, G. (2000). NF-kappaB/reV IkappaB: implications in gastrointestinal diseases. Gastroenterology 118, 1208-1228.
150. Schnare, M., Barton, G.M., Holt, A.C., Takeda, K., Akira, S., and Medzhitov, R. (2001). Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947-950.
151. Schreiber, S., Nikolaus, S., and Hampe, J. (1998). Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42, 477-484.
152. Schuppler, M., Lotzsch, K., Waidmann, M., and Autenrieth, I.B. (2004). An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect. Immun. 72, 1983-1990.
153. Scupham, A.J., Presley, L.L., Wei, B., Bent, E., Griffith, N., McPherson, M., Zhu, F., Oluwadara, O., Rao, N., Braun, J., and Borneman, J. (2006). Abundant and diverse fungal microbiota in the murine intestine. Appl. Environ. Microbiol. 72, 793-801.
154. Segain, J.P., Raingeard de la Bletiere, D., Bourreille, A., Leray, V., Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottiere, H.M., and Galmiche, J.P. (2000). Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47, 397-403.
155. Shi, Y., and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700.
156. Shkoda, A., Ruiz, P.A., Daniel, H., Kim, S.C., Rogler, G., Sartor, R.B., and Haller, D. (2007). Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology 132, 190-207.
157. Shroff, K.E., Meslin, K., and Cebra, J.J. (1995). Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63, 3904-3913.
158. Sido, B., Braunstein, J., Breitkreutz, R., Herfarth, C., and Meuer, S.C. (2000). Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J. Exp. Med. 192, 907-912.
159. Stancovski, I., and Baltimore, D. (1997). NF-kB activation: The IkB kinase revealed? Cell 91, 299-302.
160. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., and Remaut, E. (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352-1355.
161. Straus, D.S., Pascual, G., Li, M., Welch, J.S., Ricote, M., Hsiang, C.H., Sengchanthalangsy, L.L., Ghosh, G., and Glass, C.K. (2000). 15-deoxy-delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF- kappa B signaling pathway. Proc. Natl. Acad. Sci. USA. 97, 4844-4849.
162. Su, C.G., Wen, X., Bailey, S.T., Jiang, W., Rangwala, S.M., Keilbaugh, S.A., Flanigan, A., Murthy, S., Lazar, M.A., and Wu, G.D. (1999). A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104, 383-389.
163. Sundberg, J.P., Elson, C.O., Bedigian, H., and Birkenmeier, E.H. (1994). Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 107, 1726-1735.
164. Suzuki, N., Suzuki, S., Duncan, G.S., Millar, D.G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., et al. (2002). Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-756.
165. Swidsinski, A., Ladhoff, A., Pemthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., and Lochs, H. (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54.
166. Swidsinski, A., Loening-Baucke, V., Lochs, H., and Hale, L.P. (2005). Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J. Gastroenterol. 11, 1131-1140.
167. Ukena, S.N., Westendorf, A.M., Hansen, W., Rohde, M., Geffers, R., Coldewey, S., Suerbaum, S., Buer, J., and Gunzer, F. (2005). The host response to the probiotic Escherichia coli strain Nissie 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC. Med. Genet. 6, 43.
168. Ulisse, S., Gionchetti, P., D'Alo, S., Russo, F.P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M.G., Campieri, M., and De Simone, C. (2001). Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol. 96, 2691-2699.
169. Vandenbroucke, K., Hans, W., Van Huysse, J., Neirynck, S., Demetter, P., Remaut, E., Rottiers, P., and Steidler, L. (2004). Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127, 502-513.
170. Waidmann, M., Bechtold, O., Frick, J., Lehr, H., Schubert, S., Dobrindt, U., Loeffler, J., Bohn, E., and Autenneth, I. (2003). Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125, 162-177.
171. Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp-von Meissner, B., Schlee, M., Enders, C., Sonnenbom, U. Nuding, S., Bengmark, S., Fellermann, K., et al. (2004). NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect. Immun. 72, 5750-5758.
172. Wehkamp, J., Salzman, N.H., Porter, E., Nuding, S., Weichenthal, M., Petras, R.E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., et al. (2005). Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA. 102, 18129-18134.
173. Wesche, H., Gao, X., Li, X., Kirschning, C.J., Stark, G.R., and Cao, Z. (1999). IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274, 19403-19410.
174. Williams, I.R. (2004). Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol. Res. 29, 283-292.
175. Wu, J., and Kaufman, R.J. (2006). From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ. 13, 374-384.
176. Xue, X., Piao, J.H., Nakajima, A., Sakon-Komazawa, S., Kojima, Y., Mori, K., Yagita, H., Okumura, K., Harding, H., and Nakano, H. (2005). Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. J. Biol. Chem. 280, 33917-33925 Epub 32005 Aug 33917.
177. Yan, F., and Polk, D.B. (2002). Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277, 50959-50965.
178. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Manning, A.M., Anderson, J.S., Mann, M., Mercurio, F., and Ben-Neriah, Y. (1998). Identification of the receptor component of the IkB-ubiquitin ligase. Nature 396, 590-594.
179. Zarember, K.A., and Godowski, P.J. (2002). Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168, 554-561.
180. Zhang, G., and Ghosh, S. (2000). Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J. Endotoxin Res. 6, 453-457.
181. Zhang, G., and Ghosh, S. (2001). Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 107, 13-19.
182. Zhang, K., and Kaufman, R.J. (2006). The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66, S102-109.
183. Zhao, L., and Ackerman, S.L. (2006). Endoplasmic reticulum stress in health and disease. Curr. Opin. Cell Biol. 18, 444-452.